Studies on the interaction between human serum albumin and [Rh2(OAc)2(bpy)2(H2O)2](OAc)2

Journal of Inorganic Biochemistry

Volumn 66, Issue 3, 1997, Pages 187-192

  Trynda Lemiesz, Lilianna ^a   Pruchnik, Florian P ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN; RHODIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; SPECTROSCOPY;

2,2'-DIPYRIDYL; BILIRUBIN; CHROMATOGRAPHY; HEME; HUMANS; ORGANOMETALLIC COMPOUNDS; RHODIUM; SERUM ALBUMIN; SPECTRUM ANALYSIS; WARFARIN;

EID: 0030889248     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(96)00202-4     Document Type: Article

References (29)

1. D. C. Carter and J. X. Ho, Adv. Protein Chem. 45, 152 (1994).
2. T. Peters, Jr., Adv. Protein Chem. 37, 161 (1985).
3. X. M. He and D. C. Carter, Nature 358, 209 (1992).
4. J. X. Ho, E. W. Holowachuk, E. J. Norton, P. D. Twigg, and D. C. Carter, Eur. J. Biochem. 215, 201 (1993).
5. D. C. Carter and X. M. He, Science 249, 302 (1990).
6. L. M. Hall, R. J. Speer, and H. J. Ridgway, J. Clin. Hematol. Oncol. 10, 25 (1980).
7. J. L. Bear, R. A. Howard, and A. M. Denis, Current Chemother. 1321 (1978).
8. F. A. Cotton and R. A. Walton, Multiple Bonds between Metal Atoms, Clarendon Press, Oxford, 1993.
9. E. B. Boyar and S. D. Robinson, Coord. Chem. Rev. 50, 109 (1983).
10. F. P. Pruchnik, Pure Appl. Chem. 61, 795 (1989).
11. F. P. Pruchnik and D. Dus, J. Inorg. Biochem. 61, 55 (1996).
12. F. P. Pruchnik, G. Kluczewska, A. Wilczok, U. Mazurek, and T. Wilczok, J. Inorg. Biochem., to appear.
13. F. P. Pruchnik, M. Bień, and T. Lachowicz, Metal Based Drugs 3, 185 (1996); M. Bien, T. M. Lachowicz, A. Rybka, F. P. Pruchnik, and L. Trynda, ibid., to appear.
14. F. P. Pruchnik, M. Bień, and T. Lachowicz, Metal Based Drugs 3, 185 (1996); M. Bien, T. M. Lachowicz, A. Rybka, F. P. Pruchnik, and L. Trynda, ibid., to appear.
15. G. H. Beaven, S. H. Chen, A. d'Albis, and W. B. Gratzer, Eur. J. Biochem. 41, 539 (1974).
16. G. Blauer, D. Harmatz, and J. Snir, Biochem. Biophys. Acta 278, 68 (1972).
17. L. Natkaniec and F. P. Pruchnik, J. Chem. Soc., Dalton Trans. 3261 (1994).
18. A. M. Dennis, R. A. Howard, and J. L. Bear, Inorg. Chim. Acta 66, L31 (1982).
19. S. F. Mason, Molecular Optical Activity and the Chiral Discrimination, Cambridge University Press, Cambridge, 1982.
20. D. Freifelder, Physical Biochemistry: Applications to Biochemistry and Molecular Biology, W. H. Freeman, San Francisco, 1976, pp. 410-443.
21. Y. Ozeki, Y. Kurono, T. Yotsuyangi, and K. Ikeda, Chem. Pharm. Bull. 28, 535 (1980).
22. M. Otagivi, Y. Otagivi, and J. M. Perrin, Int. J. Pharmaceut. 2, 283 (1978).
23. G. Sudlow, D. J. Birkett, and D. N. Wade, Mol. Pharmacol. 11, 824 (1975).
24. G. Sudlow, D. J. Birkett, and D. N. Wade, Mol. Pharmacol. 12, 1052 (1976).
25. T. Peters, Jr., Clin. Chem. 23, 5 (1977).
26. Z. Hrkal, M. Kodiczek, Z. Vodrazka, B. Meloun, and L. Moravek, Int. J. Biochem. 9, 349 (1978).
27. G. Blauer, D. Harmatz, and A. Naparstek, FEBS Lett. 53 (1970).
28. L. Trynda, H. Przywarska-Boniecka, and T. Kosciukiewicz, Inorg. Chim. Acta 135, 55 (1987).
29. O. J. M. Bos, J. P. M. Remijn, J. E. Fischer, J. Witing, and L. H. M. Janssen, Biochem. Pharmac. 37, 3905 (1988).